Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]CPPC PET Imaging in ALS
NCT05602142Phase 2Not yet recruiting
- Sponsor
- Johns Hopkins University
- Start
- Nov 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of 11C-CPPC in amyotrophic lateral sclerosis (ALS), sponsored by Johns Hopkins University. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
11C-CPPC
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT05602142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05602142.